

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.60898590 |
| 2 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.60898590 |
| 3 | defense response to fungus (GO:0050832) | 5.25489176 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 5.16189762 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 5.16189762 |
| 6 | response to fungus (GO:0009620) | 4.89787954 |
| 7 | pentose-phosphate shunt (GO:0006098) | 4.80867094 |
| 8 | disruption of cells of other organism (GO:0044364) | 4.58008924 |
| 9 | killing of cells of other organism (GO:0031640) | 4.58008924 |
| 10 | respiratory burst (GO:0045730) | 4.56164232 |
| 11 | response to peptidoglycan (GO:0032494) | 4.55677827 |
| 12 | neutrophil mediated immunity (GO:0002446) | 4.53138765 |
| 13 | NADPH regeneration (GO:0006740) | 4.51963071 |
| 14 | leukocyte aggregation (GO:0070486) | 4.49904974 |
| 15 | proline biosynthetic process (GO:0006561) | 4.45235843 |
| 16 | reactive oxygen species biosynthetic process (GO:1903409) | 4.37611383 |
| 17 | glycosphingolipid catabolic process (GO:0046479) | 4.27641360 |
| 18 | neutrophil activation involved in immune response (GO:0002283) | 4.26153375 |
| 19 | polyketide metabolic process (GO:0030638) | 4.08858287 |
| 20 | doxorubicin metabolic process (GO:0044598) | 4.08858287 |
| 21 | daunorubicin metabolic process (GO:0044597) | 4.08858287 |
| 22 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.07267654 |
| 23 | sequestering of metal ion (GO:0051238) | 4.03496006 |
| 24 | glycolipid catabolic process (GO:0019377) | 3.95911791 |
| 25 | protein localization to endosome (GO:0036010) | 3.88371855 |
| 26 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.88272428 |
| 27 | oligosaccharide catabolic process (GO:0009313) | 3.77449684 |
| 28 | regulation of translational fidelity (GO:0006450) | 3.72700178 |
| 29 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70112471 |
| 30 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.68341124 |
| 31 | iron ion import (GO:0097286) | 3.67666954 |
| 32 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.58344905 |
| 33 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.57173217 |
| 34 | cellular extravasation (GO:0045123) | 3.54816548 |
| 35 | embryonic process involved in female pregnancy (GO:0060136) | 3.46405053 |
| 36 | glycoside metabolic process (GO:0016137) | 3.44775541 |
| 37 | pore complex assembly (GO:0046931) | 3.38186947 |
| 38 | myeloid leukocyte mediated immunity (GO:0002444) | 3.37816493 |
| 39 | negative regulation of phagocytosis (GO:0050765) | 3.36486207 |
| 40 | glucose catabolic process (GO:0006007) | 3.34412618 |
| 41 | ceramide catabolic process (GO:0046514) | 3.33064780 |
| 42 | negative regulation of growth of symbiont in host (GO:0044130) | 3.32614177 |
| 43 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.32614177 |
| 44 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.32614177 |
| 45 | regulation of growth of symbiont in host (GO:0044126) | 3.32614177 |
| 46 | neutrophil activation (GO:0042119) | 3.30739413 |
| 47 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.27669209 |
| 48 | alpha-linolenic acid metabolic process (GO:0036109) | 3.27647427 |
| 49 | leukocyte mediated cytotoxicity (GO:0001909) | 3.27132373 |
| 50 | regulation of cholesterol homeostasis (GO:2000188) | 3.23012937 |
| 51 | COPII vesicle coating (GO:0048208) | 3.21360258 |
| 52 | macrophage differentiation (GO:0030225) | 3.19237651 |
| 53 | granulocyte activation (GO:0036230) | 3.17930575 |
| 54 | superoxide anion generation (GO:0042554) | 3.17191764 |
| 55 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.10721248 |
| 56 | pentose metabolic process (GO:0019321) | 3.10480643 |
| 57 | plasma lipoprotein particle assembly (GO:0034377) | 3.06539574 |
| 58 | NADP metabolic process (GO:0006739) | 3.04816197 |
| 59 | cell killing (GO:0001906) | 3.04364899 |
| 60 | regulation of early endosome to late endosome transport (GO:2000641) | 3.04134614 |
| 61 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.01952041 |
| 62 | epithelial cell-cell adhesion (GO:0090136) | 3.00967596 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 2.99237130 |
| 64 | proline metabolic process (GO:0006560) | 2.97654868 |
| 65 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.97114827 |
| 66 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.94800343 |
| 67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.94800343 |
| 68 | NADH metabolic process (GO:0006734) | 2.94291171 |
| 69 | protein-lipid complex assembly (GO:0065005) | 2.93641235 |
| 70 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.89484193 |
| 71 | membrane lipid catabolic process (GO:0046466) | 2.86625389 |
| 72 | leukotriene metabolic process (GO:0006691) | 2.81821187 |
| 73 | vesicle coating (GO:0006901) | 2.77869246 |
| 74 | sphingolipid catabolic process (GO:0030149) | 2.77102356 |
| 75 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.75241538 |
| 76 | B cell mediated immunity (GO:0019724) | 2.74740067 |
| 77 | response to thyroid hormone (GO:0097066) | 2.74464468 |
| 78 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.71746282 |
| 79 | IMP metabolic process (GO:0046040) | 2.70240679 |
| 80 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.69078031 |
| 81 | mitotic chromosome condensation (GO:0007076) | 2.66852503 |
| 82 | progesterone metabolic process (GO:0042448) | 2.66082965 |
| 83 | intestinal absorption (GO:0050892) | 2.65469648 |
| 84 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.63919398 |
| 85 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.63232198 |
| 86 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.61062157 |
| 87 | negative regulation of interleukin-12 production (GO:0032695) | 2.59980955 |
| 88 | regulation of RNA export from nucleus (GO:0046831) | 2.59320750 |
| 89 | cellular protein complex localization (GO:0034629) | 2.58240763 |
| 90 | regulation of translational termination (GO:0006449) | 2.57562403 |
| 91 | protein export from nucleus (GO:0006611) | 2.57444593 |
| 92 | regulation of cholesterol storage (GO:0010885) | 2.55737320 |
| 93 | DNA unwinding involved in DNA replication (GO:0006268) | 2.55673870 |
| 94 | cysteine metabolic process (GO:0006534) | 2.55336896 |
| 95 | glucose 6-phosphate metabolic process (GO:0051156) | 2.54937000 |
| 96 | low-density lipoprotein particle clearance (GO:0034383) | 2.53866129 |
| 97 | maternal placenta development (GO:0001893) | 2.53509870 |
| 98 | protein complex localization (GO:0031503) | 2.53298475 |
| 99 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.53125460 |
| 100 | positive regulation by symbiont of host defense response (GO:0052509) | 2.52300919 |
| 101 | modulation by symbiont of host defense response (GO:0052031) | 2.52300919 |
| 102 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.52300919 |
| 103 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.52300919 |
| 104 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.52300919 |
| 105 | modulation by symbiont of host immune response (GO:0052553) | 2.52300919 |
| 106 | actin nucleation (GO:0045010) | 2.52216730 |
| 107 | response to arsenic-containing substance (GO:0046685) | 2.51587054 |
| 108 | IMP biosynthetic process (GO:0006188) | 2.51067265 |
| 109 | protein localization to kinetochore (GO:0034501) | 2.50170481 |
| 110 | angiotensin maturation (GO:0002003) | 2.50137626 |
| 111 | regulation of leukocyte degranulation (GO:0043300) | 2.49987054 |
| 112 | mRNA stabilization (GO:0048255) | 2.49969560 |
| 113 | RNA stabilization (GO:0043489) | 2.49969560 |
| 114 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.49503884 |
| 115 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.49084626 |
| 116 | fructose metabolic process (GO:0006000) | 2.48805132 |
| 117 | mannose metabolic process (GO:0006013) | 2.48158475 |
| 118 | barbed-end actin filament capping (GO:0051016) | 2.47966284 |
| 119 | nitrogen cycle metabolic process (GO:0071941) | 2.47304841 |
| 120 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.47035058 |
| 121 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.46622634 |
| 122 | activation of Rac GTPase activity (GO:0032863) | 2.46367774 |
| 123 | chronic inflammatory response (GO:0002544) | 2.44650888 |
| 124 | response to laminar fluid shear stress (GO:0034616) | 2.44029483 |
| 125 | regulation of vitamin metabolic process (GO:0030656) | 2.43069395 |
| 126 | neutrophil chemotaxis (GO:0030593) | 2.42486994 |
| 127 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.41586360 |
| 128 | primary alcohol catabolic process (GO:0034310) | 2.41002844 |
| 129 | leukotriene biosynthetic process (GO:0019370) | 2.40590936 |
| 130 | regulation of superoxide anion generation (GO:0032928) | 2.40395766 |
| 131 | neutrophil migration (GO:1990266) | 2.40113393 |
| 132 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.39367990 |
| 133 | leukocyte cell-cell adhesion (GO:0007159) | 2.38346220 |
| 134 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.37536703 |
| 135 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.37483020 |
| 136 | monosaccharide biosynthetic process (GO:0046364) | 2.36840673 |
| 137 | pinocytosis (GO:0006907) | 2.35399198 |
| 138 | positive regulation of nuclease activity (GO:0032075) | 2.35320777 |
| 139 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.35186408 |
| 140 | response to host immune response (GO:0052572) | 2.35186408 |
| 141 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.34333866 |
| 142 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.34015301 |
| 143 | detection of other organism (GO:0098543) | 2.33359429 |
| 144 | nuclear pore complex assembly (GO:0051292) | 2.33228181 |
| 145 | response to muramyl dipeptide (GO:0032495) | 2.33085966 |
| 146 | regulation of mast cell activation (GO:0033003) | 2.32902289 |
| 147 | regulation of mast cell degranulation (GO:0043304) | 2.32307809 |
| 148 | ER-nucleus signaling pathway (GO:0006984) | 2.31942437 |
| 149 | protein retention in ER lumen (GO:0006621) | 2.31178406 |
| 150 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.30959597 |
| 151 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.30802024 |
| 152 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.30236159 |
| 153 | nuclear pore organization (GO:0006999) | 2.30220656 |
| 154 | peptide catabolic process (GO:0043171) | 2.29992821 |
| 155 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.29881079 |
| 156 | amyloid precursor protein catabolic process (GO:0042987) | 2.29072117 |
| 157 | hydrogen peroxide metabolic process (GO:0042743) | 2.28700295 |
| 158 | positive regulation of lamellipodium assembly (GO:0010592) | 2.28699024 |
| 159 | osteoclast differentiation (GO:0030316) | 2.28512456 |
| 160 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.27624213 |
| 161 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.27291432 |
| 162 | hepatocyte apoptotic process (GO:0097284) | 2.27083944 |
| 163 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.26664716 |
| 164 | natural killer cell mediated immunity (GO:0002228) | 2.26655102 |
| 165 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.26655102 |
| 166 | tetrahydrofolate metabolic process (GO:0046653) | 2.26555844 |
| 167 | negative regulation of fatty acid transport (GO:2000192) | 2.26339754 |
| 168 | detection of bacterium (GO:0016045) | 2.26082869 |
| 169 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.25984012 |
| 170 | aldehyde catabolic process (GO:0046185) | 2.25401263 |
| 171 | regulation of chemokine biosynthetic process (GO:0045073) | 2.24959814 |
| 172 | interaction with symbiont (GO:0051702) | 2.23690127 |
| 173 | sulfur amino acid catabolic process (GO:0000098) | 2.23474668 |
| 174 | positive regulation of mast cell activation (GO:0033005) | 2.23426463 |
| 175 | regulation of cholesterol metabolic process (GO:0090181) | 2.23064558 |
| 176 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.22574569 |
| 177 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.22486525 |
| 178 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.22063763 |
| 179 | * nucleobase-containing small molecule interconversion (GO:0015949) | 2.21097867 |
| 180 | DNA strand elongation (GO:0022616) | 2.19483667 |
| 181 | cellular response to zinc ion (GO:0071294) | 2.19384738 |
| 182 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.17720682 |
| 183 | urea cycle (GO:0000050) | 2.16144067 |
| 184 | urea metabolic process (GO:0019627) | 2.16144067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.16832753 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.45158184 |
| 3 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.08290570 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.85626030 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.81603948 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.76382003 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.75152237 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40195766 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.38636176 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.29751347 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.24808921 |
| 12 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13374254 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12880005 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.10596981 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.07508825 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02524170 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.01847465 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.96904651 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.92920822 |
| 20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.91412191 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89131850 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88173644 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.87814759 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 1.86477923 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84704592 |
| 26 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83948382 |
| 27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.80966636 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80325076 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.78621407 |
| 30 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.75197543 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74120217 |
| 32 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.73663149 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.69907606 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68054442 |
| 35 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.67839992 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.67675299 |
| 37 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63747672 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.61002835 |
| 39 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.57197602 |
| 40 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.54799660 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53914368 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53258202 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52679046 |
| 44 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.51703488 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.48538346 |
| 46 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.48420971 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.47642201 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46668279 |
| 49 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46402285 |
| 50 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.46383530 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.46073281 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.43641231 |
| 53 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.41991180 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41821417 |
| 55 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40865370 |
| 56 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.40016002 |
| 57 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.38602618 |
| 58 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38213351 |
| 59 | MAF_26560356_Chip-Seq_TH1_Human | 1.37868690 |
| 60 | MYB_26560356_Chip-Seq_TH2_Human | 1.37356160 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36937224 |
| 62 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.36866345 |
| 63 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.36384919 |
| 64 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36044924 |
| 65 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.35752280 |
| 66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.33462219 |
| 67 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33096654 |
| 68 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.33083173 |
| 69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32720022 |
| 70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32607002 |
| 71 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.32560026 |
| 72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31264076 |
| 73 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30989760 |
| 74 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.30977526 |
| 75 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.30398654 |
| 76 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.29273178 |
| 77 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28715217 |
| 78 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.26001075 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25951472 |
| 80 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.25778349 |
| 81 | * MYB_26560356_Chip-Seq_TH1_Human | 1.23595749 |
| 82 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23246934 |
| 83 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.22429116 |
| 84 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.21667556 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.21177918 |
| 86 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19434749 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.18050339 |
| 88 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.17929205 |
| 89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15834980 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15662171 |
| 91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14705052 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12849118 |
| 93 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12254912 |
| 94 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.12134861 |
| 95 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.11332657 |
| 96 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.09502739 |
| 97 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.08747426 |
| 98 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08511635 |
| 99 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.07552025 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07061615 |
| 101 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06441645 |
| 102 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06441645 |
| 103 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06143151 |
| 104 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05615136 |
| 105 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04966881 |
| 106 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.04901593 |
| 107 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.04032162 |
| 108 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.03078960 |
| 109 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02180374 |
| 110 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01658648 |
| 111 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.01556096 |
| 112 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.01226831 |
| 113 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01204601 |
| 114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01056522 |
| 115 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.00787412 |
| 116 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00360259 |
| 117 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.99648749 |
| 118 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99608483 |
| 119 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98671990 |
| 120 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97839971 |
| 121 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97326818 |
| 122 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96621763 |
| 123 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.96105528 |
| 124 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.95766663 |
| 125 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95080479 |
| 126 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.95036419 |
| 127 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.93985959 |
| 128 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93874727 |
| 129 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.92832481 |
| 130 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92809700 |
| 131 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92024642 |
| 132 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91705453 |
| 133 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91235220 |
| 134 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91234706 |
| 135 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91033963 |
| 136 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.91007476 |
| 137 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90798139 |
| 138 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89774507 |
| 139 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.89060317 |
| 140 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88758354 |
| 141 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88755188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.67540131 |
| 2 | MP0003436_decreased_susceptibility_to | 3.42079357 |
| 3 | MP0003303_peritoneal_inflammation | 3.34302098 |
| 4 | MP0005360_urolithiasis | 2.65055746 |
| 5 | MP0009785_altered_susceptibility_to | 2.61435559 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.53673362 |
| 7 | MP0002419_abnormal_innate_immunity | 2.37112265 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 2.24794905 |
| 9 | MP0009278_abnormal_bone_marrow | 2.19888234 |
| 10 | MP0003693_abnormal_embryo_hatching | 2.14235299 |
| 11 | MP0004233_abnormal_muscle_weight | 2.09321974 |
| 12 | MP0004185_abnormal_adipocyte_glucose | 2.08750279 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.06586071 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.03924847 |
| 15 | MP0005025_abnormal_response_to | 2.02716409 |
| 16 | MP0001835_abnormal_antigen_presentation | 1.96410871 |
| 17 | MP0003724_increased_susceptibility_to | 1.93888817 |
| 18 | MP0003186_abnormal_redox_activity | 1.90551223 |
| 19 | MP0009840_abnormal_foam_cell | 1.87787970 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.86393469 |
| 21 | MP0010307_abnormal_tumor_latency | 1.84744341 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.83985822 |
| 23 | MP0001545_abnormal_hematopoietic_system | 1.83985822 |
| 24 | MP0003300_gastrointestinal_ulcer | 1.77913577 |
| 25 | MP0005058_abnormal_lysosome_morphology | 1.77366227 |
| 26 | MP0005076_abnormal_cell_differentiation | 1.76097429 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.66665558 |
| 28 | MP0000858_altered_metastatic_potential | 1.66550568 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.65479603 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.64087154 |
| 31 | MP0002009_preneoplasia | 1.62904938 |
| 32 | MP0001853_heart_inflammation | 1.61393895 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.59899434 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.59898364 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.58334784 |
| 36 | MP0005365_abnormal_bile_salt | 1.56674608 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.54506318 |
| 38 | MP0000343_altered_response_to | 1.53752501 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.53090764 |
| 40 | MP0002405_respiratory_system_inflammati | 1.48725162 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.48532851 |
| 42 | MP0000490_abnormal_crypts_of | 1.46880025 |
| 43 | MP0004957_abnormal_blastocyst_morpholog | 1.44865353 |
| 44 | MP0003566_abnormal_cell_adhesion | 1.44696391 |
| 45 | MP0008260_abnormal_autophagy | 1.43246802 |
| 46 | MP0000685_abnormal_immune_system | 1.42291841 |
| 47 | MP0009764_decreased_sensitivity_to | 1.41684574 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.40399791 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.40065099 |
| 50 | MP0008469_abnormal_protein_level | 1.39785759 |
| 51 | MP0001819_abnormal_immune_cell | 1.39779986 |
| 52 | MP0001849_ear_inflammation | 1.39105256 |
| 53 | MP0002420_abnormal_adaptive_immunity | 1.39104567 |
| 54 | MP0004858_abnormal_nervous_system | 1.38120913 |
| 55 | MP0000604_amyloidosis | 1.36394639 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.36013848 |
| 57 | MP0002723_abnormal_immune_serum | 1.33703229 |
| 58 | MP0008057_abnormal_DNA_replication | 1.33538573 |
| 59 | MP0005023_abnormal_wound_healing | 1.30545696 |
| 60 | MP0003111_abnormal_nucleus_morphology | 1.30516310 |
| 61 | MP0001800_abnormal_humoral_immune | 1.30338488 |
| 62 | MP0002877_abnormal_melanocyte_morpholog | 1.29727422 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.28822201 |
| 64 | MP0004947_skin_inflammation | 1.25840885 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 1.24407885 |
| 66 | MP0003448_altered_tumor_morphology | 1.22405231 |
| 67 | MP0010094_abnormal_chromosome_stability | 1.20901916 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 1.20293047 |
| 69 | MP0003077_abnormal_cell_cycle | 1.18871869 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18748851 |
| 71 | MP0010329_abnormal_lipoprotein_level | 1.17053495 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.16681962 |
| 73 | MP0002398_abnormal_bone_marrow | 1.15931946 |
| 74 | MP0000609_abnormal_liver_physiology | 1.15630467 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 1.15587986 |
| 76 | MP0003075_altered_response_to | 1.15460119 |
| 77 | MP0000537_abnormal_urethra_morphology | 1.14369512 |
| 78 | MP0002796_impaired_skin_barrier | 1.13095787 |
| 79 | MP0000716_abnormal_immune_system | 1.12661504 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.12366464 |
| 81 | MP0010234_abnormal_vibrissa_follicle | 1.11846523 |
| 82 | MP0001790_abnormal_immune_system | 1.11788700 |
| 83 | MP0005387_immune_system_phenotype | 1.11788700 |
| 84 | MP0003091_abnormal_cell_migration | 1.09860987 |
| 85 | MP0003329_amyloid_beta_deposits | 1.09485404 |
| 86 | MP0000689_abnormal_spleen_morphology | 1.08231679 |
| 87 | MP0001661_extended_life_span | 1.07632617 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 1.07323803 |
| 89 | MP0002429_abnormal_blood_cell | 1.07127912 |
| 90 | MP0002722_abnormal_immune_system | 1.06577955 |
| 91 | MP0005310_abnormal_salivary_gland | 1.05626497 |
| 92 | MP0010678_abnormal_skin_adnexa | 1.05567672 |
| 93 | MP0001727_abnormal_embryo_implantation | 1.04068728 |
| 94 | MP0002019_abnormal_tumor_incidence | 1.03601935 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 1.03169562 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 1.02261705 |
| 97 | MP0005666_abnormal_adipose_tissue | 1.02013968 |
| 98 | MP0002166_altered_tumor_susceptibility | 1.01484426 |
| 99 | MP0006082_CNS_inflammation | 1.01213096 |
| 100 | MP0002006_tumorigenesis | 1.00797739 |
| 101 | MP0005409_darkened_coat_color | 1.00475997 |
| 102 | MP0009763_increased_sensitivity_to | 1.00166326 |
| 103 | MP0005083_abnormal_biliary_tract | 0.98799859 |
| 104 | MP0001873_stomach_inflammation | 0.98654686 |
| 105 | MP0002086_abnormal_extraembryonic_tissu | 0.97900527 |
| 106 | MP0000598_abnormal_liver_morphology | 0.97588528 |
| 107 | MP0002098_abnormal_vibrissa_morphology | 0.94649991 |
| 108 | MP0001764_abnormal_homeostasis | 0.94472396 |
| 109 | MP0005501_abnormal_skin_physiology | 0.93306880 |
| 110 | MP0003252_abnormal_bile_duct | 0.92074725 |
| 111 | MP0000747_muscle_weakness | 0.91500473 |
| 112 | MP0001851_eye_inflammation | 0.91133371 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.90399284 |
| 114 | MP0001666_abnormal_nutrient_absorption | 0.89152042 |
| 115 | MP0001730_embryonic_growth_arrest | 0.88914807 |
| 116 | MP0003984_embryonic_growth_retardation | 0.88520206 |
| 117 | MP0005380_embryogenesis_phenotype | 0.87750799 |
| 118 | MP0001672_abnormal_embryogenesis/_devel | 0.87750799 |
| 119 | MP0002080_prenatal_lethality | 0.86777438 |
| 120 | MP0000350_abnormal_cell_proliferation | 0.86580480 |
| 121 | MP0005332_abnormal_amino_acid | 0.86257140 |
| 122 | MP0005671_abnormal_response_to | 0.85412149 |
| 123 | MP0008007_abnormal_cellular_replicative | 0.85102775 |
| 124 | MP0002088_abnormal_embryonic_growth/wei | 0.84664947 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.84508341 |
| 126 | MP0000627_abnormal_mammary_gland | 0.84465921 |
| 127 | MP0000678_abnormal_parathyroid_gland | 0.84181542 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.84134168 |
| 129 | MP0001663_abnormal_digestive_system | 0.83904230 |
| 130 | MP0001216_abnormal_epidermal_layer | 0.83465840 |
| 131 | MP0005174_abnormal_tail_pigmentation | 0.82729324 |
| 132 | MP0005166_decreased_susceptibility_to | 0.82146526 |
| 133 | MP0001915_intracranial_hemorrhage | 0.82110444 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.81836826 |
| 135 | MP0004019_abnormal_vitamin_homeostasis | 0.81531069 |
| 136 | MP0005621_abnormal_cell_physiology | 0.80736051 |
| 137 | MP0005408_hypopigmentation | 0.80309421 |
| 138 | MP0005248_abnormal_Harderian_gland | 0.78505721 |
| 139 | MP0000371_diluted_coat_color | 0.76611891 |
| 140 | MP0003868_abnormal_feces_composition | 0.75690729 |
| 141 | MP0003941_abnormal_skin_development | 0.75037667 |
| 142 | MP0002896_abnormal_bone_mineralization | 0.73791017 |
| 143 | MP0000313_abnormal_cell_death | 0.73553990 |
| 144 | MP0001697_abnormal_embryo_size | 0.70999321 |
| 145 | MP0009672_abnormal_birth_weight | 0.69412799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.08390822 |
| 2 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.49146286 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.04961950 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.52310914 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.39728940 |
| 6 | Chronic obstructive pulmonary disease (HP:0006510) | 4.06286494 |
| 7 | Obstructive lung disease (HP:0006536) | 4.06286494 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 3.80531187 |
| 9 | Gingivitis (HP:0000230) | 3.74241356 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.67436137 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.67436137 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.67436137 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.35856231 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.20713980 |
| 15 | Recurrent skin infections (HP:0001581) | 3.19036990 |
| 16 | Periodontitis (HP:0000704) | 3.14083501 |
| 17 | Urticaria (HP:0001025) | 3.13139449 |
| 18 | Asymmetry of the thorax (HP:0001555) | 3.12726728 |
| 19 | Flat acetabular roof (HP:0003180) | 3.11820402 |
| 20 | Cellulitis (HP:0100658) | 2.74032076 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 2.73878165 |
| 22 | Thrombocytosis (HP:0001894) | 2.72895978 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 2.70701271 |
| 24 | Myositis (HP:0100614) | 2.69701893 |
| 25 | Pustule (HP:0200039) | 2.69455605 |
| 26 | Hyperacusis (HP:0010780) | 2.63257458 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.61175106 |
| 28 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.60939417 |
| 29 | Subacute progressive viral hepatitis (HP:0006572) | 2.60399846 |
| 30 | Interstitial pulmonary disease (HP:0006530) | 2.56185687 |
| 31 | Stomatitis (HP:0010280) | 2.54016140 |
| 32 | Dysmetric saccades (HP:0000641) | 2.52862610 |
| 33 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.48396297 |
| 34 | Termporal pattern (HP:0011008) | 2.45770387 |
| 35 | Insidious onset (HP:0003587) | 2.45770387 |
| 36 | Abnormal platelet volume (HP:0011876) | 2.45621826 |
| 37 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.40626750 |
| 38 | Joint hemorrhage (HP:0005261) | 2.39146381 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 2.38262968 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 2.37394743 |
| 41 | Meningitis (HP:0001287) | 2.32347947 |
| 42 | Gingival bleeding (HP:0000225) | 2.31415912 |
| 43 | Petechiae (HP:0000967) | 2.28721579 |
| 44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27993957 |
| 45 | Mucopolysacchariduria (HP:0008155) | 2.27993957 |
| 46 | Hemorrhage of the eye (HP:0011885) | 2.27978660 |
| 47 | Thin bony cortex (HP:0002753) | 2.27775964 |
| 48 | Abnormality of iron homeostasis (HP:0011031) | 2.26882977 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.25129932 |
| 50 | Osteomyelitis (HP:0002754) | 2.23188632 |
| 51 | Cholecystitis (HP:0001082) | 2.22595007 |
| 52 | Abnormal gallbladder physiology (HP:0012438) | 2.22595007 |
| 53 | Vertebral compression fractures (HP:0002953) | 2.22470329 |
| 54 | Increased serum ferritin (HP:0003281) | 2.19960350 |
| 55 | Loss of speech (HP:0002371) | 2.19929557 |
| 56 | Increased mean platelet volume (HP:0011877) | 2.19853877 |
| 57 | Skin nodule (HP:0200036) | 2.17481668 |
| 58 | Ankyloglossia (HP:0010296) | 2.14667759 |
| 59 | Orchitis (HP:0100796) | 2.14542976 |
| 60 | Epistaxis (HP:0000421) | 2.13804020 |
| 61 | Bone pain (HP:0002653) | 2.13327170 |
| 62 | Abnormality of the Achilles tendon (HP:0005109) | 2.13030485 |
| 63 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.12155381 |
| 64 | Chest pain (HP:0100749) | 2.11761374 |
| 65 | IgM deficiency (HP:0002850) | 2.10442116 |
| 66 | Spastic diplegia (HP:0001264) | 2.09144080 |
| 67 | Hypobetalipoproteinemia (HP:0003563) | 2.09050289 |
| 68 | Recurrent viral infections (HP:0004429) | 2.08860412 |
| 69 | Orthostatic hypotension (HP:0001278) | 2.08659922 |
| 70 | Micronodular cirrhosis (HP:0001413) | 2.07856630 |
| 71 | Deep venous thrombosis (HP:0002625) | 2.07557560 |
| 72 | Multiple lipomas (HP:0001012) | 2.07354347 |
| 73 | Cutaneous melanoma (HP:0012056) | 2.07114537 |
| 74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04355785 |
| 75 | Abdominal distention (HP:0003270) | 2.04313740 |
| 76 | Xanthomatosis (HP:0000991) | 2.04225553 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.04027183 |
| 78 | Malnutrition (HP:0004395) | 2.03685059 |
| 79 | Intrahepatic cholestasis (HP:0001406) | 2.03332806 |
| 80 | Skin ulcer (HP:0200042) | 2.03313275 |
| 81 | Agnosia (HP:0010524) | 2.01416841 |
| 82 | Osteolytic defects of the hand bones (HP:0009699) | 2.01231574 |
| 83 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01231574 |
| 84 | Fat malabsorption (HP:0002630) | 2.00448547 |
| 85 | Nausea (HP:0002018) | 2.00176970 |
| 86 | Vasculitis (HP:0002633) | 2.00109389 |
| 87 | Abnormality of nucleobase metabolism (HP:0010932) | 2.00091060 |
| 88 | Multiple enchondromatosis (HP:0005701) | 1.98925895 |
| 89 | Pathologic fracture (HP:0002756) | 1.98025321 |
| 90 | Achilles tendon contracture (HP:0001771) | 1.97336262 |
| 91 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96561901 |
| 92 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96561901 |
| 93 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96561901 |
| 94 | Hyperammonemia (HP:0001987) | 1.95571511 |
| 95 | Reticulocytosis (HP:0001923) | 1.95536265 |
| 96 | Abnormality of oral frenula (HP:0000190) | 1.95057914 |
| 97 | Sparse lateral eyebrow (HP:0005338) | 1.94270677 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 1.93568096 |
| 99 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.92566104 |
| 100 | Spontaneous hematomas (HP:0007420) | 1.92413721 |
| 101 | Progressive external ophthalmoplegia (HP:0000590) | 1.92216249 |
| 102 | Abnormality of T cell physiology (HP:0011840) | 1.91633722 |
| 103 | Impaired platelet aggregation (HP:0003540) | 1.91021265 |
| 104 | Abnormal platelet function (HP:0011869) | 1.91021265 |
| 105 | Hypercholesterolemia (HP:0003124) | 1.90878979 |
| 106 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.89570657 |
| 107 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.88929619 |
| 108 | Reduced antithrombin III activity (HP:0001976) | 1.88587545 |
| 109 | Leiomyosarcoma (HP:0100243) | 1.88117687 |
| 110 | Uterine leiomyosarcoma (HP:0002891) | 1.88117687 |
| 111 | Abnormality of the prostate (HP:0008775) | 1.87940385 |
| 112 | Upper motor neuron abnormality (HP:0002127) | 1.87775506 |
| 113 | Cervical subluxation (HP:0003308) | 1.87320356 |
| 114 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.87121174 |
| 115 | Thrombophlebitis (HP:0004418) | 1.87069624 |
| 116 | Esophageal varix (HP:0002040) | 1.86952883 |
| 117 | Thoracic kyphosis (HP:0002942) | 1.86867329 |
| 118 | Leukocytosis (HP:0001974) | 1.86613558 |
| 119 | Germ cell neoplasia (HP:0100728) | 1.85602783 |
| 120 | Cheilitis (HP:0100825) | 1.85387618 |
| 121 | Distal lower limb amyotrophy (HP:0008944) | 1.85234682 |
| 122 | Cholelithiasis (HP:0001081) | 1.84525711 |
| 123 | Cardiomegaly (HP:0001640) | 1.84180763 |
| 124 | Abnormal cartilage morphology (HP:0002763) | 1.83532589 |
| 125 | Back pain (HP:0003418) | 1.81151207 |
| 126 | Anorexia (HP:0002039) | 1.81104847 |
| 127 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80949010 |
| 128 | Abnormality of the thoracic spine (HP:0100711) | 1.80679360 |
| 129 | Peritonitis (HP:0002586) | 1.80035496 |
| 130 | Hepatocellular carcinoma (HP:0001402) | 1.79974171 |
| 131 | Menorrhagia (HP:0000132) | 1.78529968 |
| 132 | Progressive muscle weakness (HP:0003323) | 1.78242549 |
| 133 | Myocardial infarction (HP:0001658) | 1.77834645 |
| 134 | Cerebral inclusion bodies (HP:0100314) | 1.77631007 |
| 135 | Pseudobulbar signs (HP:0002200) | 1.76677170 |
| 136 | Hemoptysis (HP:0002105) | 1.76203071 |
| 137 | Progressive hearing impairment (HP:0001730) | 1.75604361 |
| 138 | Hypolipoproteinemia (HP:0010981) | 1.75423514 |
| 139 | Abnormality of the gastric mucosa (HP:0004295) | 1.75017406 |
| 140 | Curly hair (HP:0002212) | 1.74795609 |
| 141 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74515921 |
| 142 | Metaphyseal cupping (HP:0003021) | 1.73716391 |
| 143 | Coarse hair (HP:0002208) | 1.72830822 |
| 144 | Arterial thrombosis (HP:0004420) | 1.72158072 |
| 145 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.72086784 |
| 146 | Hypotension (HP:0002615) | 1.71324421 |
| 147 | Abnormality of complement system (HP:0005339) | 1.70582863 |
| 148 | Hyperparathyroidism (HP:0000843) | 1.70109732 |
| 149 | Hypoglycemic coma (HP:0001325) | 1.69574861 |
| 150 | Lower limb hyperreflexia (HP:0002395) | 1.69554865 |
| 151 | Abnormality of purine metabolism (HP:0004352) | 1.69549037 |
| 152 | Granulocytopenia (HP:0001913) | 1.69306111 |
| 153 | Poikiloderma (HP:0001029) | 1.69066440 |
| 154 | Acanthocytosis (HP:0001927) | 1.69012080 |
| 155 | Prolonged bleeding time (HP:0003010) | 1.68311562 |
| 156 | Gastrointestinal carcinoma (HP:0002672) | 1.67282880 |
| 157 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.67282880 |
| 158 | Tetraparesis (HP:0002273) | 1.65783492 |
| 159 | Elevated alkaline phosphatase (HP:0003155) | 1.65650563 |
| 160 | Insomnia (HP:0100785) | 1.65616446 |
| 161 | Spinal cord compression (HP:0002176) | 1.65252549 |
| 162 | Renal cell carcinoma (HP:0005584) | 1.65075064 |
| 163 | Eosinophilia (HP:0001880) | 1.64952366 |
| 164 | Hepatosplenomegaly (HP:0001433) | 1.64397478 |
| 165 | Degeneration of anterior horn cells (HP:0002398) | 1.63417391 |
| 166 | Abnormality of the anterior horn cell (HP:0006802) | 1.63417391 |
| 167 | Abnormal foot bone ossification (HP:0010675) | 1.62950456 |
| 168 | Distal lower limb muscle weakness (HP:0009053) | 1.62226719 |
| 169 | Abnormality of the gallbladder (HP:0005264) | 1.62158964 |
| 170 | Steatorrhea (HP:0002570) | 1.61447107 |
| 171 | Abnormal tarsal ossification (HP:0008369) | 1.60049531 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMG1 | 3.28319987 |
| 2 | IRAK4 | 3.16357744 |
| 3 | ERN1 | 2.83610255 |
| 4 | ICK | 2.71782059 |
| 5 | PRPF4B | 2.34452444 |
| 6 | STK10 | 2.26295075 |
| 7 | TESK2 | 2.15362946 |
| 8 | PKN2 | 2.14968688 |
| 9 | FGFR4 | 2.06157360 |
| 10 | BLK | 2.02905256 |
| 11 | MAP2K3 | 1.96438988 |
| 12 | EPHB1 | 1.96071341 |
| 13 | TESK1 | 1.92563002 |
| 14 | WEE1 | 1.91706029 |
| 15 | GRK6 | 1.86565803 |
| 16 | TRIB3 | 1.83165931 |
| 17 | CSK | 1.73947267 |
| 18 | EIF2AK3 | 1.73616983 |
| 19 | RIPK4 | 1.73301442 |
| 20 | PAK4 | 1.70472765 |
| 21 | LRRK2 | 1.67743461 |
| 22 | MAP3K14 | 1.65635219 |
| 23 | BTK | 1.64204661 |
| 24 | NEK2 | 1.61277799 |
| 25 | CAMK1D | 1.60384237 |
| 26 | SIK1 | 1.56262650 |
| 27 | CDC7 | 1.56204091 |
| 28 | KSR2 | 1.54204683 |
| 29 | CDK12 | 1.54101114 |
| 30 | TYK2 | 1.50478424 |
| 31 | TRPM7 | 1.49189693 |
| 32 | IRAK3 | 1.48473458 |
| 33 | PTK6 | 1.46778551 |
| 34 | MAP4K1 | 1.45150913 |
| 35 | FLT3 | 1.43645118 |
| 36 | MAP3K3 | 1.42445704 |
| 37 | ERBB4 | 1.40030236 |
| 38 | MAP3K2 | 1.37787061 |
| 39 | TEC | 1.37131109 |
| 40 | PIM1 | 1.35307268 |
| 41 | TBK1 | 1.34389293 |
| 42 | MAP3K8 | 1.33642943 |
| 43 | RPS6KA4 | 1.32152207 |
| 44 | ACVR1B | 1.30372866 |
| 45 | RIPK1 | 1.29826489 |
| 46 | TAOK3 | 1.26984224 |
| 47 | EEF2K | 1.26069662 |
| 48 | PBK | 1.24544564 |
| 49 | EPHA2 | 1.23003888 |
| 50 | SCYL2 | 1.20083954 |
| 51 | MAP3K11 | 1.16946712 |
| 52 | BRSK2 | 1.11196760 |
| 53 | PDGFRA | 1.10515842 |
| 54 | MST4 | 1.10344902 |
| 55 | ZAP70 | 1.10102198 |
| 56 | MST1R | 1.09856535 |
| 57 | TAOK2 | 1.09508315 |
| 58 | ALK | 1.08201140 |
| 59 | TTN | 1.07967396 |
| 60 | MAP3K13 | 1.05229813 |
| 61 | STK4 | 1.04887664 |
| 62 | RPS6KB2 | 1.04849564 |
| 63 | PRKG2 | 1.03930592 |
| 64 | MATK | 1.03285927 |
| 65 | CDK4 | 1.00660866 |
| 66 | JAK3 | 0.97743978 |
| 67 | CDK7 | 0.97391825 |
| 68 | PDPK1 | 0.97084622 |
| 69 | NEK1 | 0.94799463 |
| 70 | CAMK1G | 0.93944391 |
| 71 | FGFR3 | 0.93790505 |
| 72 | BCKDK | 0.92695289 |
| 73 | NEK9 | 0.92177230 |
| 74 | MAP3K1 | 0.91056036 |
| 75 | BMX | 0.89129613 |
| 76 | KDR | 0.88994901 |
| 77 | LATS2 | 0.88660965 |
| 78 | FRK | 0.85821906 |
| 79 | FES | 0.85171058 |
| 80 | MAP3K10 | 0.84894372 |
| 81 | PIM2 | 0.84298485 |
| 82 | BUB1 | 0.84066539 |
| 83 | TSSK6 | 0.82831406 |
| 84 | MET | 0.80126732 |
| 85 | MTOR | 0.79087808 |
| 86 | MAP2K2 | 0.78827576 |
| 87 | IKBKB | 0.78555408 |
| 88 | CDK6 | 0.78133462 |
| 89 | HCK | 0.78026563 |
| 90 | BMPR2 | 0.77866877 |
| 91 | TAOK1 | 0.73252039 |
| 92 | PRKD3 | 0.72860236 |
| 93 | EIF2AK1 | 0.72132522 |
| 94 | JAK2 | 0.70846952 |
| 95 | STK3 | 0.68783351 |
| 96 | ABL2 | 0.67918346 |
| 97 | NME2 | 0.67525165 |
| 98 | ATR | 0.66868636 |
| 99 | FGR | 0.66147456 |
| 100 | MAPKAPK3 | 0.65920748 |
| 101 | KSR1 | 0.65641067 |
| 102 | MAPK4 | 0.65128870 |
| 103 | MARK3 | 0.64897076 |
| 104 | MAP3K9 | 0.64510246 |
| 105 | PTK2 | 0.62586655 |
| 106 | RPS6KC1 | 0.61933290 |
| 107 | RPS6KL1 | 0.61933290 |
| 108 | RPS6KA6 | 0.61549446 |
| 109 | IKBKE | 0.61502033 |
| 110 | CSF1R | 0.61162494 |
| 111 | IRAK2 | 0.61098009 |
| 112 | MAPK11 | 0.60656408 |
| 113 | LIMK1 | 0.59842952 |
| 114 | MELK | 0.58782167 |
| 115 | AKT2 | 0.58314516 |
| 116 | RET | 0.56955751 |
| 117 | CLK1 | 0.56847667 |
| 118 | TTK | 0.56679129 |
| 119 | YES1 | 0.56500000 |
| 120 | ITK | 0.53655389 |
| 121 | LYN | 0.53350334 |
| 122 | AURKB | 0.53285796 |
| 123 | PLK1 | 0.52672112 |
| 124 | CDC42BPA | 0.51480641 |
| 125 | SYK | 0.49490988 |
| 126 | PRKCD | 0.48810024 |
| 127 | PDK1 | 0.47920032 |
| 128 | CHUK | 0.47194419 |
| 129 | LCK | 0.46264407 |
| 130 | KIT | 0.46147385 |
| 131 | MAPKAPK2 | 0.46036519 |
| 132 | MAP3K5 | 0.45181059 |
| 133 | STK24 | 0.44308344 |
| 134 | NEK6 | 0.42593945 |
| 135 | PDK2 | 0.42433993 |
| 136 | CHEK2 | 0.41891104 |
| 137 | PRKAA2 | 0.39878263 |
| 138 | BRD4 | 0.39872881 |
| 139 | BRAF | 0.38162344 |
| 140 | RPS6KB1 | 0.37363350 |
| 141 | TAF1 | 0.36826142 |
| 142 | MAP3K12 | 0.35671811 |
| 143 | ILK | 0.33769177 |
| 144 | CAMKK2 | 0.33104195 |
| 145 | CHEK1 | 0.31886201 |
| 146 | LMTK2 | 0.31463156 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.05359085 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.51406455 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37154790 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.29319281 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.26429003 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20679878 |
| 7 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.17156477 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.07929504 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 1.96965193 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.88502820 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.75802579 |
| 12 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.66428178 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56496358 |
| 14 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.56110355 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47517123 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.37174486 |
| 17 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.35469459 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35066553 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 1.31577061 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.30993573 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30788296 |
| 22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.28896731 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28009780 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.26066609 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24160737 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.22960573 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.21302240 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.21203084 |
| 29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19136041 |
| 30 | Endometrial cancer_Homo sapiens_hsa05213 | 1.17875486 |
| 31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17765037 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17723855 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.17421963 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17208450 |
| 35 | * Glutathione metabolism_Homo sapiens_hsa00480 | 1.14747886 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12592885 |
| 37 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10742777 |
| 38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09173768 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07773829 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.07111722 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.07014049 |
| 42 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.06566280 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05208691 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05169075 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05001311 |
| 46 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.02775732 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.01753553 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.01323700 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.00668432 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.00015681 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.98125567 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97027356 |
| 53 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93750262 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 0.92562039 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92500907 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.92294055 |
| 57 | Apoptosis_Homo sapiens_hsa04210 | 0.92204059 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.92203037 |
| 59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91967811 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.91194231 |
| 61 | Peroxisome_Homo sapiens_hsa04146 | 0.90641773 |
| 62 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.90563850 |
| 63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.88985733 |
| 64 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.88093139 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86650117 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.86517695 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86354754 |
| 68 | Prostate cancer_Homo sapiens_hsa05215 | 0.86121594 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84500948 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 0.84012405 |
| 71 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83939766 |
| 72 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.83228361 |
| 73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83089765 |
| 74 | Influenza A_Homo sapiens_hsa05164 | 0.82944789 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82578968 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82272323 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82213792 |
| 78 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.81863054 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.81495596 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81282598 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.81185950 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.80809175 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79254040 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79047586 |
| 85 | Cell cycle_Homo sapiens_hsa04110 | 0.77713777 |
| 86 | Homologous recombination_Homo sapiens_hsa03440 | 0.76761427 |
| 87 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76435837 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76256965 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.75863443 |
| 90 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75239550 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75096580 |
| 92 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.74688174 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74352493 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.74144428 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.73605844 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73068468 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.72900514 |
| 98 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72811078 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.72127949 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70776793 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70491876 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69589395 |
| 103 | RNA transport_Homo sapiens_hsa03013 | 0.69526242 |
| 104 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.69246969 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68470632 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67428561 |
| 107 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67048377 |
| 108 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65458818 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65112637 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.64530704 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64233719 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63946414 |
| 113 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.63773490 |
| 114 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63682573 |
| 115 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63370408 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63025913 |
| 117 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61970310 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60581250 |
| 119 | Bladder cancer_Homo sapiens_hsa05219 | 0.60418828 |
| 120 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59145265 |
| 121 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59141063 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.59035442 |
| 123 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.58348638 |
| 124 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58198071 |
| 125 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57997452 |
| 126 | ABC transporters_Homo sapiens_hsa02010 | 0.57508739 |
| 127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57487864 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56932806 |
| 129 | Bile secretion_Homo sapiens_hsa04976 | 0.56865038 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56656559 |
| 131 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.56641889 |
| 132 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55013640 |
| 133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54974775 |
| 134 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54018858 |
| 135 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53630696 |
| 136 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53181713 |
| 137 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51710193 |
| 138 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51541147 |
| 139 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51431414 |
| 140 | Proteasome_Homo sapiens_hsa03050 | 0.51191370 |
| 141 | Hepatitis C_Homo sapiens_hsa05160 | 0.50929323 |
| 142 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49687697 |
| 143 | Glioma_Homo sapiens_hsa05214 | 0.48701080 |
| 144 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47599324 |
| 145 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46456917 |

